Cargando…

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population

Detalles Bibliográficos
Autores principales:	Hooijberg, Femke, Boekel, Laura, Vogelzang, Erik H, Leeuw, Maureen, Boers, Maarten, van Vollenhoven, Ronald, Lems, Willem F, Nurmohamed, Mike T, Wolbink, Gertjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579459/ https://www.ncbi.nlm.nih.gov/pubmed/33106791 http://dx.doi.org/10.1016/S2665-9913(20)30286-1

Ejemplares similares

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period
por: Boekel, Laura, et al.
Publicado: (2022)

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
por: Boekel, Laura, et al.
Publicado: (2021)

Perspective of patients with autoimmune diseases on COVID-19 vaccination
por: Boekel, Laura, et al.
Publicado: (2021)

Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands
por: Boekel, Laura, et al.
Publicado: (2023)

Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine
por: Lems, Willem, et al.
Publicado: (2021)

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study
por: Boekel, Laura, et al.
Publicado: (2022)

Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients
por: Boekel, L, et al.
Publicado: (2022)

Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated
por: Raadsen, Reinder, et al.
Publicado: (2023)

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
por: Boekel, Laura, et al.
Publicado: (2021)

Outcome measures for adherence data from a medication event monitoring system: A literature review
por: Hartman, Linda, et al.
Publicado: (2018)

Spinning straw into gold: description of a disruptive rheumatology research platform inspired by the COVID-19 pandemic
por: Boekel, L., et al.
Publicado: (2021)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

Mentoring is more important than ever
por: Heemstra, Jennifer M., et al.
Publicado: (2022)

An unfavorable body composition is common in early arthritis patients: A case control study
por: Turk, Samina A., et al.
Publicado: (2018)

Lipolysis: more than just a lipase
por: Birnbaum, Morris J.
Publicado: (2003)

Importance of nociplastic pain in patients with rheumatic diseases
por: Alcántara Montero, Antonio
Publicado: (2023)

Progress in islet transplantation is more important than ever
por: Bornstein, Stefan R., et al.
Publicado: (2022)

Diabetes and covid-19: more than the sum of two morbidities
por: Pititto, Bianca de Almeida, et al.
Publicado: (2020)

RAS inhibition and COVID-19: more questions than answers?
por: Kerneis, Mathieu, et al.
Publicado: (2021)

Immunogenicity of TNF-Inhibitors
por: Atiqi, Sadaf, et al.
Publicado: (2020)

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
por: Antonelli, Alessandro, et al.
Publicado: (2021)

COVID-19 in patients with rheumatic disease: finally, a denominator
por: Wallace, Daniel J
Publicado: (2021)

Long COVID in inflammatory rheumatic diseases—what's in a name?
por: Calabrese, Leonard H
Publicado: (2023)

Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up
por: Vogelzang, E. H., et al.
Publicado: (2018)

Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review
por: van Tuyl, Lilian HD, et al.
Publicado: (2014)

A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks
por: den Uyl, Debby, et al.
Publicado: (2014)

SARS-CoV-2 vaccination in IBD: more pros than cons
por: D’Amico, Ferdinando, et al.
Publicado: (2021)

Energy restriction in people with multiple sclerosis: Is time more important than calories?
por: Ghezzi, Laura
Publicado: (2022)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021)

Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters
por: de Jong, Tamarah D., et al.
Publicado: (2016)

The COVID-19 vaccines rush: participatory community engagement matters more than ever
por: Burgess, Rochelle Ann, et al.
Publicado: (2021)

More than honour, humanitarian health-care workers need life-saving protection
por: Langlois, Etienne V, et al.
Publicado: (2021)

More than an outcome: a person-centered, ecological framework for eating disorder recovery
por: Kenny, Therese E., et al.
Publicado: (2023)

Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial
por: Wientjes, Maike H. M., et al.
Publicado: (2021)

Changing COVID-19 outcomes in patients with rheumatic disease—are we really getting better at this?
por: Gianfrancesco, Milena A, et al.
Publicado: (2021)

Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
por: Bechman, Katie, et al.
Publicado: (2023)

Covid-19 and the need for perinatal mental health professionals: now more than ever before
por: Hynan, Michael T.
Publicado: (2020)

B cells: more than just for antibodies in SARS-CoV-2 vaccine responses
por: Paley, Michael A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jjp5uh958tanqv5p1gegsblma7